Skip to main content Accessibility help
×
Home

Impact of Haemophilus influenzae type b vaccination on the incidence of invasive Haemophilus influenzae disease in France, 15 years after its introduction

  • S. GEORGES (a1), A. LEPOUTRE (a1), H. DABERNAT (a2) and D. LEVY-BRUHL (a1)

Summary

We assessed the impact of Haemophilus influenzae type b (Hib) vaccination, introduced in France in early 1993, on the incidence of invasive Haemophilus influenzae (Hi) disease up to 2008. The incidence of Hi meningitis fell from 0·9/100 000 in 1991–1992 to 0·09/100 000 in 1996–2008, with a marked decline (96%) in children aged <5 years, including infants aged <3 months, from 12 to 0·4/100 000. The incidence of invasive Hi disease also decreased in children aged <15 years from 6 to 0·7/100 000, remained stable in the 15–64 years age group at about 0·5/100 000, and increased slightly from 2·0 to 2·4/100 000 in persons aged >64 years. No emergence of non-encapsulated or encapsulated non-vaccine serotypes was observed. These findings confirm the major direct impact of Hib vaccination on the incidence of Hi invasive disease in children and the indirect benefit of vaccination for infants too young to be vaccinated.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Impact of Haemophilus influenzae type b vaccination on the incidence of invasive Haemophilus influenzae disease in France, 15 years after its introduction
      Available formats
      ×

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Impact of Haemophilus influenzae type b vaccination on the incidence of invasive Haemophilus influenzae disease in France, 15 years after its introduction
      Available formats
      ×

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Impact of Haemophilus influenzae type b vaccination on the incidence of invasive Haemophilus influenzae disease in France, 15 years after its introduction
      Available formats
      ×

Copyright

Corresponding author

*Author for correspondence: Dr D. Levy-Bruhl, Institut de Veille Sanitaire, 12 rue du Val d'Osne, 94410, Saint Maurice, France. (Email: d.levybruhl@invs.sante.fr)

References

Hide All
1.Decker, MD, et al. Comparative trial in infants of four conjugate Haemophilus influenzae type b vaccines. Journal of Pediatrics 1992; 120: 184189.
2.Peltola, H, Kilpi, T, Anttila, M. Rapid disappearance of Haemophilus influenzae type b meningitis after routine childhood immunisation with conjugate vaccines. Lancet 1992; 340: 592594.
3.Anon. The immunization schedule. Bulletin Epidemiologique Hebdomadaire 1993; 1: 12.
4.Boucher, J, et al. Epidemiology of Haemophilus influenzae b infections in 2 French districts. Bulletin Epidemiologique Hebdomadaire 1992; 1: 12.
5.Dabernat, H, Delmas, C. Haemophilus influenzae, b serotype and the others. Bulletin Epidemiologique Hebdomadaire 1994; 7: 3132.
6.Roure, C, Begue, P. Vaccination against Haemophilus influenzae type b. Recommendations of the Technical Committee on Immunization. Bulletin Epidemiologique Hebdomadaire 1992; 18: 7778.
7.Georges, S, et al. Sixteeen years of surveillance of bacterial invasive infections in France (1991–2006) through the EPIBAC network. Revue Francophone des Laboratoires 2008; 407: 3543.
8.Falla, TJ, et al. PCR for capsular typing of Haemophilus influenzae. Journal of Clinical Microbiology 1994; 32: 23822386.
9.Dabernat, H, et al. Bacterial meningitis in France. Study in 6 mainland districts in 1995–1997. Medecine et Maladies Infectieuses 2000; 30: 588594.
10.Dabernat, H, Delmas, C. Activities of the National Reference Centre for Haemophilus influenzae, 1994–1995. First post-vaccination years. Medecine et Maladies Infectieuses 1996; 26: 698703.
11.Dabernat, H, Delmas, C. Activities of the National Reference Centre for Haemophilus influenzae, 1996–1997: The decline of the b type. Medecine et Maladies Infectieuses 1998; 28: 940946.
12.Dabernat, H, et al. Genotyping of type b Haemophilus influenzae strains, comparison of strains collected before and during vaccine availability. Medecine et Maladies Infectieuses 2005; 35: 205212.
13.Fonteneau, L, Guthmann, JP, Levy-Bruhl, D. Estimations of vaccination coverage at 24 months of age through the health certificates – 2004–2007. Report of the Institut de veille sanitaire, 2010 (http://www.invs.sante.fr/publications/).
14.Ribeiro, GS, et al. Haemophilus influenzae meningitis 5 years after introduction of the Haemophilus influenzae type b conjugate vaccine in Brazil. Vaccine 2007; 22: 44204428.
15.Ladhani, SN. Two decades of experience with the Haemophilus influenzae serotype b conjugate vaccine in the United Kingdom. Clinical Therapeutics Journal. 2012; 34: 385399.
16.Miranzi Sde, S, de Moraes, SA, de Freitas, IC. Impact of the Haemophilus influenzae type b vaccination program on HIB meningitis in Brazil. Cadernos de Saude Publica. 2007; 23: 16891695.
17.Heath, PT, McVernon, J. The UK Hib vaccine experience. Archives of Disease in Childhood. 2002; 86: 396399.
18.Wenger, JD. Epidemiology of Haemophilus influenzae type b disease and impact of Haemophilus influenzae type b conjugate vaccines in the United States and Canada. Pediatric Infectious Disease Journal. 1998; 17 (Suppl. 9):132136.
19.Ladhani, S, et al. Invasive Haemophilus influenzae disease, Europe, 1996–2006. Emerging Infectious Diseases 2010; 16: 455463.
20.Barbour, ML, Mayon-White, RT. The impact of conjugate vaccine on carriage of Haemophilus influenzae type b. Journal of Infectious Diseases 1995; 171: 9398.
21.McVernon, J, et al. Trends in Haemophilus influenzae type b infections in adults in England and Wales: surveillance study. British Medical Journal 2004; 329: 655658.
22.Dabernat, H, et al. Haemophilus influenzae carriage in children attending French day care centers: a molecular epidemiological study. Journal of Clinical Microbiology 2003; 41: 16641672.
23.Dworkin, MS, Park, L, Borchardt, SM. The changing epidemiology of invasive Haemophilus influenzae disease, especially in persons ⩾65 years old. Clinical Infectious Diseases 2007; 44: 810816.
24.Takala, AK, et al. Reduction of oropharyngeal carriage of Haemophilus influenzae type b (Hib) in children immunized with an Hib conjugate vaccine. Journal of Infectious Diseases 1991; 164: 982986.
25.Ladhani, S, et al. No evidence for Haemophilus influenzae serotype replacement in Europe after introduction of the Hib conjugate vaccine. Lancet Infectious Disease 2008; 8: 275276.
26.McVernon, J, Ramsay, ME, McLean, AR. Understanding the impact of Hib conjugate vaccine on transmission, immunity and disease in the United Kingdom. Epidemiology and Infection 2008; 136: 800812.
27.Bajanca, P, Caniça, M, and the Multicenter Study Group. Emergence of non-encapsulated and encapsulated non-type-b invasive Haemophilus influenzae isolates in Portugal 1989–2001. Journal of Clinical Microbiology 2004; 42: 807810.
28.Ribeiro, GS, et al. Prevention of Haemophilus influenzae type b (Hib) meningitis and emergence of serotype replacement with type a strains after introduction of Hib immunization in Brazil. Journal of Infectious Diseases 2003; 187: 109116.
29.Hubert, B, Goulet, V, Rioux, JY. Surveillance of meningococcal disease in France1990–7. Eurosurveillance 1997; 10: 7879.
30.Perrocheau, A. Evaluation of meningococcal infections surveillance in 1996 through the capture-recapture method. Report of the Institut de veille sanitaire, 2001 (http://www.invs.sante.fr/publications/).
31.Perrocheau, A. Surveillance of meningococcal invasive infections in France in 2000. Quantitative evaluation through the 3 sources capture-recapture method. Report of the Institut de veille sanitaire, 2006 (http://www.invs.sante.fr/publications/).
32.Berger, F, et al. Surveillance of meningococcal invasive infections in France in 2005. Quantitative evaluation through the 3 sources capture-recapture method. Report of the Institut de veille sanitaire, 2010 (http://www.invs.sante.fr/publications/).
33.Peltola, H. Haemophilus influenzae type b disease and vaccination in Europe: lessons learned. Pediatric Infectious Disease Journal. 1998; 17 (Suppl.9): 126132.

Keywords

Type Description Title
EXCEL
Supplementary materials

Levy-Bruhl Supplementary Material
Appendix

 Excel (48 KB)
48 KB

Impact of Haemophilus influenzae type b vaccination on the incidence of invasive Haemophilus influenzae disease in France, 15 years after its introduction

  • S. GEORGES (a1), A. LEPOUTRE (a1), H. DABERNAT (a2) and D. LEVY-BRUHL (a1)

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed